Projects funded by the NCN
Semaglutide and neurodevelopment: investigating risks arising from prenatal exposure to a widely popular drug for diabetes and obesity
2023/51/B/NZ7/02360
Keywords:
semaglutide neurodevelopment neurotoxicity apoptosis autophagy epigenetic status behavioral disorders prenatal exposure GLP-1 receptor agonist fetal development,
Descriptors:
- NZ7_15: Toxicology
- NZ3_5: Molecular neurobiology
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 8
Call: OPUS 26 - announced on 2023-09-18
Amount awarded: 2 996 320 PLN
Project start date (Y-m-d): 2024-10-01
Project end date (Y-m-d): 2028-09-30
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.